Stock listing
IBO Stock Price, News, Filings & Events — Impact Biomedical, Inc.
Selected listing: IBO · AMEX · USD · US
This page tracks Impact Biomedical, Inc.'s IBO:AMEX listing on AMEX in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following IBO:AMEX. IBO:AMEX is the stock-level entry point for investors researching Impact Biomedical, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Impact Biomedical, Inc. (ticker: IBO) is a public company based in the United States with a market capitalization of approximately $47.4 million. The company focuses on developing innovative solutions in the biomedical sector. Investors can find more information about its operations and performance on its dedicated public company page.

- Ticker
- IBO:AMEX
- Asset type
- Stock
- Market cap
- $58.2M
- Sector
- Electronic Technology
- Industry
- Electronic Equipment/Instruments
- Exchange
- AMEX
- Currency
- USD
Impact Biomedical, Inc. IBO:AMEX stock context
This page tracks Impact Biomedical, Inc.'s IBO:AMEX listing on AMEX in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following IBO:AMEX. IBO:AMEX is the stock-level entry point for investors researching Impact Biomedical, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Impact Biomedical, Inc. (ticker: IBO) is a public company based in the United States with a market capitalization of approximately $47.4 million. The company focuses on developing innovative solutions in the biomedical sector. Investors can find more information about its operations and performance on its dedicated public company page.
Latest news from Impact Biomedical, Inc.
Impact BioMedical Inc (NYSE American: IBO) Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Ltd. (previ...
September 14, 2026
Impact BioMedical Inc (NYSE American: IBO) Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Ltd. (previ...
September 11, 2026
Impact BioMedical Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing While Continuing Strategic Merger Plans
April 3, 2026
Impact Biomedical Inc (IBO) Announces 3F™ US Patent Issue
August 18, 2025
Dr Ashleys Limited and Impact BioMedical Inc. Announce Strategic Merger
June 23, 2025
Research Impact Biomedical, Inc.
Impact Biomedical, Inc. investor report
Review AI stock analysis and investor report context for IBO:AMEX.
Impact Biomedical, Inc. company profile
View the public company page for Impact Biomedical, Inc. on 6ix.
Impact Biomedical, Inc. news
Read company news and market updates connected to Impact Biomedical, Inc..
Impact Biomedical, Inc. investor events
Find investor webinars, events, and replay context for Impact Biomedical, Inc..